|
|
|
Volumn 18, Issue 14 Suppl 12, 2004, Pages 27-31
|
|
Neoadjuvant therapy with gemcitabine in breast cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DOCETAXEL;
DRUG DERIVATIVE;
EPIRUBICIN;
GEMCITABINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
HUMAN;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPIRUBICIN;
FEMALE;
FILGRASTIM;
HUMANS;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
TAXOIDS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 15544383696
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
